We are proud to present IDIMO: Research in Advanced Medical Devices for Better Control and Monitoring of Immune Response and Infections.
Under the leadership of @i+Med, this ambitious project brings together a consortium of renowned companies and technology centers in the biomedical field of the Basque Country. With a budget of 3.45 million euros and a duration of 33 months, IDIMO aims to develop innovative solutions to improve the integration and safety of implantable biomedical devices.
Areas of Focus
IDIMO focuses on four key therapeutic areas:
- Traumatology
- Ophthalmology
- Dentistry
- Urology
The project seeks to address critical challenges such as infections and adverse responses to foreign bodies, which represent an estimated annual cost of 9.5 billion euros for European healthcare systems.
The IDIMO Consortium
The consortium comprises leading companies and prestigious technology centers, including:
- AJL OPHTHALMIC
- ASPARIA GLYCOMICS
- CREATECH MEDICAL
- IMG Pharma Biotech
- INNOVATIVE TECHNOLOGIES IN BIOLOGICAL SYSTEMS
- TECNALIA
- CIC BIOMAGUNE
- GAIKER
- CIDETEC
- UPV/EHU
Dr. Virginia Sáez-Martínez, leader of the consortium, states: “IDIMO represents a unique opportunity to advance precision medicine and improve patients’ quality of life.”
Support and Funding
With support from the Basque Government through the Hazitek 2023 call, IDIMO is set to make a significant impact in the field of medical devices and strengthen the competitive landscape of the biomedical sector in the Basque Country.
For more information about this exciting initiative and to learn the full details of the project, please see the official press release from the Basque Health Cluster.